This HTML5 document contains 61 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n12http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q68149735
rdf:type
wikibase:Item
schema:description
im Juli 1988 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 1988 наукова стаття, опублікована в липні 1988 artículu científicu espublizáu en xunetu de 1988 wetenschappelijk artikel scientific article published on 01 July 1988
p:P577
wds:Q68149735-2895DEC6-F72F-43DC-B5CA-E98830723FA5
wdt:P577
1988-07-01T00:00:00Z
p:P407
wds:Q68149735-F2EFAE39-5705-49F0-A0F2-B98250FBDE2C
wdt:P407
wd:Q1860
p:P2093
wds:Q68149735-2A530A7C-E0D0-4090-8C43-F25FC8B6E3A7 wds:Q68149735-287D4005-72C0-4512-AFFA-288DCA4E61D6 wds:Q68149735-F009941E-7099-4626-8344-794E7DB81FB9 wds:Q68149735-C81973AF-22B9-4277-88CE-2CFED0A0C4AD wds:Q68149735-9F3A3D1B-8882-422E-A2A1-3745A8CBF49B wds:Q68149735-86022DFC-DD23-480C-9999-A60C790664F0 wds:Q68149735-835BB6E4-5392-42FB-B311-84FB27416BB4 wds:Q68149735-3D345952-218D-460F-870E-73BDC28765D5 wds:Q68149735-5BF16A77-003F-41CA-9943-3904B3C173EA
wdt:P2093
R L Capizzi M R Cooper J M Cruz D V Jackson E H Paschold W R Black B L Powell H B Wells R Christian
rdfs:label
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association
skos:prefLabel
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association
schema:name
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association
p:P50
wds:Q68149735-FE70B850-C72E-4A9C-B3AD-1A9886E0D997
wdt:P50
wd:Q104758257
p:P1476
wds:Q68149735-94544090-AC81-446E-B25B-0FF48334D0BD
wdt:P1476
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association
p:P304
wds:Q68149735-3A61E67B-0876-4B1F-B302-8F188C1C158C
wdt:P304
1098-1106
p:P31
wds:Q68149735-DD741C9C-FBA1-47B1-BF38-19933A55B71D
wdt:P31
wd:Q13442814
p:P921
wds:Q68149735-614F897F-E746-4839-8EF2-CE8B80035248 wds:Q68149735-3656FB53-6BB1-47F1-A553-EE11FA0919C5 wds:Q68149735-79E8EB9E-6377-45D5-B18C-E8454BB015BF
wdt:P921
wd:Q42824827 wd:Q412178 wd:Q410513
p:P698
wds:Q68149735-B421B949-200B-4BBC-AD02-22EAC6EFA44A
wdtn:P698
n11:3292710
wdt:P698
3292710
p:P1433
wds:Q68149735-D8646774-05D0-4E8C-B01C-57E20C9C78A0
wdt:P1433
wd:Q400292
p:P433
wds:Q68149735-748E646E-54EC-49D0-8346-0BDA885A7DA4
p:P478
wds:Q68149735-29BF81FE-0F01-49F1-AE3A-8E98396AF07C
wdt:P433
7
wdt:P478
6
p:P356
wds:Q68149735-9E4DA748-F591-4DB1-9E71-A800B80314D7
wdtn:P356
n12:JCO.1988.6.7.1098
wdt:P356
10.1200/JCO.1988.6.7.1098